MONTREAL, March 22, 2005 (PRIMEZONE) -- Viropro Pharma Inc., a wholly owned subsidiary of Viropro, Inc. (OTCBB:VPRO) is pleased to announce today that it has signed a major partnership for its Health Consumer Products Division with Capiltech, a leading manufacturer of homeopathic products.
According to this agreement, Viropro Pharma, Inc. has the exclusive right to sell and distribute Capiltech's product line internationally. This line consists primarily of exclusive natural and homeopathic health products with many of the ingredients or formulations sourced in Europe, Brazil and Tahiti. These products will consolidate Viropro Pharma's existing consumer products range.
Capiltech, a leading company based in Montreal, is renowned for its advanced research and development of homeopathic high quality products. It has acquired a solid reputation through the European and North American markets thanks to a large range of homeopathic products, which perfectly responded to the growing need for homeopathic products.
M. Prosper Azoulay, Vice-President of Viropro Pharma's Health Consumer Products Division, announced "I'm very pleased with the finalisation of this partnership. The launch of this new product line, expected to be in April 2005, will definitely consolidate Viropro Pharma's growing sales of health consumer products on international markets and generate substantial revenue in the short and long term."
About Viropro, Inc.
Viropro, Inc. (OTCBB:VPRO) is establishing a growth portfolio in Life Sciences markets through strategic alliances and revenue-producing acquisitions with the potential for continued shareholder value.
Viropro, Inc.'s Safe Harbor Statement
Except for any historic information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, which are subject to section 27A of the Securities Act of 1933 and section 21E of the Exchange Act of 1934, and are subject to safe harbor created by these sections. Any statements that express or involve discussions with respect to predictions, beliefs, plans, projections, objectives, goals, assumptions of future events or performances are not statements of historical fact and may be "forward looking statements". Forward looking statements in this release may be identified through the use of such words as "expects", "anticipates", "estimates", "believes", or statements indicating certain actions "may", "could", or "might" occur. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements, which involve numerous risks and uncertainties, including the Company's ability to market its products and services in a competitive environment as well as other factors.
DIRECT ALL INQUIRIES TO TRIVOR FINANCIAL COMMUNICATIONS.